Kenvue to Showcase New Clinical Data on Skin Longevity, Hydration and Sun Protection at American Academy of Dermatology Association Meeting
Kenvue Inc. (NYSE: KVUE) will present new clinical data from 14 studies at the 2025 American Academy of Dermatology Annual Meeting in Orlando, showcasing innovations in skin health and beauty products. The research focuses on their brands including Neutrogena® and Aveeno®.
Key findings include:
- Neutrogena® Collagen Bank's twice-daily use reduces collagen loss and improves skin qualities
- The 'open sandwich' method with Neutrogena® Hydro Boost Water Cream optimizes hydration for sensitive skin
- Aveeno® baby products improve infant skin hydration and barrier integrity
- Oat flour in Aveeno® products increases hyaluronic acid production by 43%
- New Neutrogena® Ultra Sheer Mineral Face Liquid SPF 70 provides 3x more UVA protection with 30% less whitening versus competitors
Kenvue Inc. (NYSE: KVUE) presenterà nuovi dati clinici provenienti da 14 studi durante il Congresso Annuale dell'American Academy of Dermatology del 2025 a Orlando, evidenziando innovazioni nei prodotti per la salute della pelle e la bellezza. La ricerca si concentra sui loro marchi, tra cui Neutrogena® e Aveeno®.
I risultati chiave includono:
- L'uso due volte al giorno di Neutrogena® Collagen Bank riduce la perdita di collagene e migliora le qualità della pelle
- Il metodo 'open sandwich' con Neutrogena® Hydro Boost Water Cream ottimizza l'idratazione per la pelle sensibile
- I prodotti per bambini Aveeno® migliorano l'idratazione della pelle infantile e l'integrità della barriera
- La farina d'avena nei prodotti Aveeno® aumenta la produzione di acido ialuronico del 43%
- Il nuovo Neutrogena® Ultra Sheer Mineral Face Liquid SPF 70 offre 3 volte più protezione UVA con il 30% in meno di sbiancamento rispetto ai concorrenti
Kenvue Inc. (NYSE: KVUE) presentará nuevos datos clínicos de 14 estudios en la Reunión Anual de la Academia Americana de Dermatología 2025 en Orlando, destacando innovaciones en productos para la salud de la piel y la belleza. La investigación se centra en sus marcas, incluyendo Neutrogena® y Aveeno®.
Los hallazgos clave incluyen:
- El uso dos veces al día de Neutrogena® Collagen Bank reduce la pérdida de colágeno y mejora las cualidades de la piel
- El método 'open sandwich' con Neutrogena® Hydro Boost Water Cream optimiza la hidratación para pieles sensibles
- Los productos para bebés de Aveeno® mejoran la hidratación de la piel infantil y la integridad de la barrera
- La harina de avena en los productos de Aveeno® aumenta la producción de ácido hialurónico en un 43%
- El nuevo Neutrogena® Ultra Sheer Mineral Face Liquid SPF 70 proporciona 3 veces más protección UVA con un 30% menos de blanqueo en comparación con los competidores
Kenvue Inc. (NYSE: KVUE)는 2025년 미국 피부과 학회 연례 회의에서 14개의 연구에서 새로운 임상 데이터를 발표하여 피부 건강 및 미용 제품의 혁신을 선보일 예정입니다. 이 연구는 Neutrogena®와 Aveeno®를 포함한 그들의 브랜드에 중점을 두고 있습니다.
주요 발견 사항은 다음과 같습니다:
- Neutrogena® Collagen Bank를 하루 두 번 사용하면 콜라겐 손실이 줄어들고 피부의 질이 개선됩니다
- Neutrogena® Hydro Boost Water Cream의 '오픈 샌드위치' 방법은 민감한 피부를 위한 수분 공급을 최적화합니다
- Aveeno® 아기 제품은 유아의 피부 수분과 장벽의 무결성을 개선합니다
- Aveeno® 제품의 귀리 가루는 히알루론산 생산을 43% 증가시킵니다
- 새로운 Neutrogena® Ultra Sheer Mineral Face Liquid SPF 70은 경쟁 제품보다 30% 덜 하얘지면서 3배 더 많은 UVA 보호를 제공합니다
Kenvue Inc. (NYSE: KVUE) présentera de nouvelles données cliniques issues de 14 études lors de la Réunion Annuelle de l'American Academy of Dermatology 2025 à Orlando, mettant en avant des innovations dans les produits de santé de la peau et de beauté. La recherche se concentre sur leurs marques, y compris Neutrogena® et Aveeno®.
Les résultats clés incluent :
- L'utilisation deux fois par jour de Neutrogena® Collagen Bank réduit la perte de collagène et améliore les qualités de la peau
- La méthode 'open sandwich' avec Neutrogena® Hydro Boost Water Cream optimise l'hydratation pour les peaux sensibles
- Les produits pour bébés Aveeno® améliorent l'hydratation de la peau des nourrissons et l'intégrité de la barrière
- La farine d'avoine dans les produits Aveeno® augmente la production d'acide hyaluronique de 43%
- Le nouveau Neutrogena® Ultra Sheer Mineral Face Liquid SPF 70 offre 3 fois plus de protection UVA avec 30% de blanchiment en moins par rapport aux concurrents
Kenvue Inc. (NYSE: KVUE) wird auf dem Jahrestreffen der American Academy of Dermatology 2025 in Orlando neue klinische Daten aus 14 Studien präsentieren, die Innovationen in der Hautgesundheit und Schönheitsprodukten zeigen. Die Forschung konzentriert sich auf ihre Marken, darunter Neutrogena® und Aveeno®.
Wichtige Ergebnisse umfassen:
- Die zweimal tägliche Anwendung von Neutrogena® Collagen Bank reduziert den Kollagenverlust und verbessert die Hautqualität
- Die 'Open Sandwich'-Methode mit Neutrogena® Hydro Boost Water Cream optimiert die Hydration für empfindliche Haut
- Aveeno® Babyprodukte verbessern die Hautfeuchtigkeit und die Barriereintegrität bei Säuglingen
- Hafermehl in Aveeno®-Produkten erhöht die Produktion von Hyaluronsäure um 43%
- Das neue Neutrogena® Ultra Sheer Mineral Face Liquid SPF 70 bietet 3-mal mehr UVA-Schutz mit 30% weniger Aufhellung im Vergleich zu Wettbewerbern
- Clinical validation of product efficacy across 14 studies
- Neutrogena SPF 70 shows 3x better UVA protection vs competitors
- Aveeno products demonstrate 43% increase in hyaluronic acid production
- Scientific proof of Neutrogena Collagen Bank's anti-aging benefits
- None.
Science Behind Iconic Brands, including NEUTROGENA® and AVEENO®, Underscores the Company’s Expertise and Commitment to Shaping the Future of Skin Health & Beauty
In findings from the 14 clinical studies detailing new Kenvue scientific research, the Company will present evidence alongside industry experts on the effectiveness of formulations behind iconic brands such as Neutrogena® and Aveeno® in cellular health for skin longevity, superior hydration, and exceptional protection against UVA sun damage. The Company’s exhibit floor booth #2503 will also feature immersive and innovative experiences from Neutrogena®, Aveeno®, NeoStrata®, Lubriderm® and Rogaine®.
“Our Skin Health and Beauty brands are at the forefront of next-generation science as high-performance products that are effective in promoting the health and longevity of skin,” said Adam Ricciardone, Head of R&D, Global Skin Health & Beauty. “The results of these clinical studies further illustrate our commitment to developing innovative, science-backed experiences for consumers that are recommended by industry experts, and our dedication to shaping a new view of care for Skin Health & Beauty in the future.”
New research being presented by Kenvue during AAD found:
- Twice daily use of Neutrogena® Collagen Bank, a facial moisturizer featuring a patented micro-peptide technology to penetrate deep surface layers that support collagen production, including the SPF formulation, in the morning diminished collagen loss during the pre-aging phase. This regimen helps improve skin radiance, fine lines, firmness, texture and elasticity, effectively reducing early signs of aging.1
- Leveraging a technique called the “open sandwich” method, where retinoids are applied either before or after moisturization with Neutrogena® Hydro Boost Water Cream, ensures optimal hydration, especially for those with sensitive skin.2
-
Applying an oat-based Aveeno® liquid wash and moisturizer regimen for infants, with products like Aveeno® Baby Eczema Therapy Wash and Aveeno® Baby Eczema Therapy Nighttime Balm, improves hydration, the integrity of the skin barrier, and also enhances the overall quality of life for infants.3 In a separate study, oat flour, a key ingredient across the entire Aveeno® product line, was also found to boost the production of hyaluronic acid (HA) by
43% , a key component for overall skin hydration.4 -
Pure mineral sunscreens with a high SPF have variability in effectiveness of UVA protection, premature aging, and aesthetics. New Neutrogena® Ultra Sheer Mineral Face Liquid SPF 70 offers 3x more UVA protection and
30% less whitening versus leading competitors, using an exclusive technology that maximizes the efficacy potential of the UV filters through proper and uniform mineral dispersion.5
More information on all studies being presented at AAD can be found here: https://kenvuepro.com/en-us/events/2025-aad-annual-meeting
About Kenvue
Kenvue Inc. is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the extraordinary power of everyday care. Our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.
Neutrogena®, Aveeno®, NeoStrata®, Lubriderm® and Rogaine® are brands of Kenvue Brands LLC, a subsidiary of Kenvue Inc.
1 Multi-decade Studies of Clinical and Pre-clinical Changes in Facial Skin Define Skin Pre-aging; Shyr, Thomas C., et al.
2 Tretinoin and Retinol Bioactivity are Retained when Layered with Adjunctive Gel-Matrix Moisturizer or a Cream Moisturizer in an “Open Sandwich” Regimen; Parsa, Ramine PhD, et al.
3 Improving Skin Hydration, Barrier Integrity and Quality of Life in Brazilian Babies with Sensitive Skin: A Clinical Study on the use of an Oat-Based Wash and Moisturizer Regimen; Santos, Sarah, et al.
4 Oat Flour Enhances Hyaluronic Acid Secretion Providing Possible Mechanism for Moisturization Effects; Besingi, Richard PhD, et al.
5 Evaluating the Variability in Effective Protection Against Ultraviolet A (UVA) Radiation-Induced Pigmentation Provided by Mineral Sunscreens; Williams, Joshua D., et al.
Cautions Concerning Forward-Looking Statements
This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding data being presented at the American Academy of Dermatologists Annual Meeting. Forward-looking statements may be identified by the use of words such as “plans,” “expects,” “will,” “anticipates,” “estimates” and other words of similar meaning. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Kenvue and its affiliates.
A list and descriptions of risks, uncertainties and other factors can be found in Kenvue’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 29, 2024 and subsequent Quarterly Reports on Form 10-Q and other filings, available at www.kenvue.com or on request from Kenvue. Kenvue and its affiliates undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or developments or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250307889299/en/
R&D Media Relations
Lindsay Hymson Schechter
lhymsons@kenvue.com
Source: Kenvue
FAQ
What are the key findings from Kenvue's (KVUE) clinical studies presented at AAD 2025?
How effective is Kenvue's (KVUE) new Neutrogena Ultra Sheer Mineral Face Liquid SPF 70?
What benefits do Kenvue's (KVUE) Aveeno baby products show in clinical trials?
How does Kenvue's (KVUE) Neutrogena Collagen Bank affect skin aging?
